One registered trial is underway, and even the definition of microdosing varies from one clinic to the next
In SELECT, semaglutide 2.4 mg reduced the risk of the composite outcome of cardiovascular death, non-fatal heart attack or non-fatal stroke compared with placebo in adults with established cardiovascular disease and BMI of at least 27 kg/m2 [8,9]
Safdarpour, S., Eidi, A., & Mortazavi, P
Furthermore, the high-dose group experienced a two-fold increase in Natural Killer (NK) cell immune cytotoxicity, proving that oral supplementation not only raises antioxidant levels but actively enhances immune defense mechanisms
In some situations, companies claim that federal approval from the FDA shields them from certain state law claims